| | Variaz. | Variaz. 5g. | Variaz. 1 gen. | Variaz. 1anno | Variaz. 3anni | Capi. (M$) |
 | AROVELLA THERAPEUTICS LIMITED | 9.09% | 0.00% | -38.46% | -59.32% | -76.00% | 11 |
| | | | | | | |
 | MODERNA, INC. | 0.71% | 12.68% | -43.20% | -34.40% | 947.71% | 57 385 |
| IQVIA HOLDINGS INC. | 1.07% | 8.56% | -24.22% | -12.86% | 38.71% | 40 468 |
 | LONZA GROUP AG | 5.08% | 3.14% | -32.67% | -22.42% | 56.34% | 39 851 |
| SEAGEN INC. | 3.06% | 8.39% | 16.00% | 14.09% | 159.79% | 33 010 |
 | CELLTRION, INC. | 6.85% | 12.46% | -13.38% | -34.11% | -9.93% | 18 371 |
| ICON PUBLIC LIMITED COMPANY | 1.44% | 9.84% | -28.76% | 1.60% | 49.11% | 17 936 |
| ALNYLAM PHARMACEUTICALS, INC. | 0.82% | 7.59% | -13.02% | -15.90% | 107.34% | 17 820 |
 | PHARMARON BEIJING CO., LTD. | 6.83% | 5.69% | -1.24% | -35.04% | 319.72% | 15 724 |
| BIO-TECHNE CORPORATION | 2.16% | 7.83% | -31.81% | -19.19% | 73.40% | 13 840 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 6.58% | 5.24% | -18.26% | -46.41% | 130.16% | 12 996 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.60% | 10.87% | -39.93% | -38.48% | 68.79% | 11 498 |
| UNITED THERAPEUTICS CORPORATION | -0.79% | 8.92% | 10.58% | 32.75% | 209.28% | 10 824 |
| QIAGEN N.V. | 4.02% | 6.73% | -16.10% | -3.95% | 15.51% | 10 606 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | -0.28% | -0.93% | 4.34% | 46.19% | 261.37% | 10 215 |
 | GENSCRIPT BIOTECH CORPORATION | 5.52% | 12.35% | -16.96% | -15.74% | 53.37% | 7 708 |
| | | | | | | |
| | Media | 3.04% | 7.96% | -16.58% | -12.26% | 165.38% | |
| | Media ponderata per Capi. | 2.77% | 8.36% | -20.50% | -15.72% | 251.75% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
